Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

---

Summary

• President's Associate Presidential Professor
• Director, PGY2 Pediatric Pharmacy Residency
• Director, Pediatric Pharmacotherapy Degree Option

---

Publications & Presentations

1. Johnson P N, Miller J L. Peer Review as a Professional Obligation: Steps and Tips to Becoming a High-Quality Reviewer. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2024; 29 : 570-577

2. Parman A, Miller J L, Neely S, Johnson P N, Gupta N. Rates of Stress Ulcer Prophylaxis Deprescribing in Children Receiving Usual versus High-Dose Corticosteroids in the Pediatric Intensive Care Unit with Status Asthmaticus. Hospital pharmacy. 2024; 59 : 677-683

3. Patel K, Thomson S, Vijayan M, Makoni M, Johnson P N, Stephens K, Neely S, Miller J L. Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit. Frontiers in Pediatrics. 2024; 12 : 1-8

4. Chang E, Parman A, Johnson P N, Stephens K, Neely S, Dasari N, Kassa N, Miller J L. Gabapentin for Delirium in Infants in the Neonatal Intensive Care Unit. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2024; 29 : 487-493

5. Ropp D L, Johnson P N, Stephens K, Neely S, Chaaban H, Miller J L. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of perinatology : official journal of the California Perinatal Association. 2024; 44 : 1478-1484

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Avery Parman). Date: 2024.


2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.


3. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.


4. Society of Critical Care Medicine Presidential Citation. Date: 2022.


5. Oklahoma Foundation for Excellence. Oklahoma Medal for Excellence Finalist in Teaching and Administration. Date: 2022.

Education

1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.


2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.


3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.


4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.

Administrative Assignments

no results